Login to Your Account



Degussa Spinout Elbion AG Draws EUR25M Series A Round

By Douglas Merrill


Wednesday, January 19, 2005
Elbion AG reeled in €25 million in Germany's first significant biotech financing of 2005. The company, which was formed through a management buyout of some of Degussa AG's pharmaceutical assets in 2002, concentrates on the discovery and development of small molecules that are effective against inflammatory and central nervous system diseases. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription